Recro Pharma, Inc.
Records under this name other than patents Recro Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,881,663 | Method of Treating Pain in Elderly Patients with Mild Renal Impairment now held by Alkermes Pharma Ireland Limited In force · High confidence | In force | High confidence | |
| US 11,458,145 | Methods of Administering Intravenous Meloxicam in a Bolus Dose now held by Alkermes Pharma Ireland Limited In force · High confidence | In force | High confidence | |
| US 9,795,559 | Intranasal Dexmedetomidine Compositions and Methods of Use Thereof now held by Baudax Bio, Inc. Lapsed on the fee record Ended Oct 24, 2025 · High confidence | Lapsed on the fee record | Ended Oct 24, 2025 | High confidence |
| US 8,512,727 | Nanoparticulate meloxicam formulations now held by Alkermes Pharma Ireland Limited Lapsed on the fee record Ended Aug 20, 2025 · High confidence | Lapsed on the fee record | Ended Aug 20, 2025 | High confidence |
| US 7,759,496 | Imidazol Derivatives Having Affinity for Alpha 2 Receptors Activity now held by Baudax Bio, Inc. Term ended Term ended Apr 10, 2025 · High confidence | Term ended | Term ended Apr 10, 2025 | High confidence |
| US 8,323,641 | Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer now held by Alkermes Pharma Ireland Limited Lapsed on the fee record Ended Dec 4, 2024 · High confidence | Lapsed on the fee record | Ended Dec 4, 2024 | High confidence |
| US 10,682,311 | Intranasal Dexmedetomidine Compositions And Methods Of Use Thereof now held by Baudax Bio, Inc. Lapsed on the fee record Ended Jun 16, 2024 · High confidence | Lapsed on the fee record | Ended Jun 16, 2024 | High confidence |
| US 10,463,673 | Nanoparticulate Meloxicam Formulations now held by Alkermes Pharma Ireland Limited Term ended Term ended Feb 24, 2024 · Medium confidence | Term ended | Term ended Feb 24, 2024 | Medium confidence |
| US 10,471,067 | Nanoparticulate Meloxicam Formulations now held by Alkermes Pharma Ireland Limited Term ended Term ended Feb 24, 2024 · Medium confidence | Term ended | Term ended Feb 24, 2024 | Medium confidence |
| US 10,709,713 | Nanoparticulate Meloxicam Formulations now held by Alkermes Pharma Ireland Limited Term ended Term ended Feb 24, 2024 · Medium confidence | Term ended | Term ended Feb 24, 2024 | Medium confidence |